Trial Profile
A Phase 1, Placebo-Controlled Trial to Evaluate the Impact of Intravenous (IV) Bendavia (MTP-131) on Endothelial Reactivity Dysfunction Induced by Cigarette Smoking
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Elamipretide (Primary)
- Indications Cardiovascular disorders
- Focus Pharmacodynamics
- Sponsors Stealth Peptides
- 17 Oct 2014 New trial record